<DOC>
	<DOCNO>NCT01507701</DOCNO>
	<brief_summary>The aim pilot study NorCAPITAL trial investigate feasibility safety drug clonidine adolescent chronic fatigue syndrome ( CFS ) . Specifically , investigator want assess appropriate dosage relation ) plasma concentration level clonidine , b ) orthostatic cardiovascular response ( pulse blood pressure responses rise ) , c ) report possible adverse effect . A possible beneficial effect clonidine adolescent CFS investigate NorCAPITAL , randomize , placebo-controlled , double blind trial .</brief_summary>
	<brief_title>Pilot Study NorCAPITAL Trial</brief_title>
	<detailed_description />
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Fatigue Syndrome , Chronic</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<criteria>Persisting constantly relapse fatigue last 3 month Functional disability result fatigue degree prevent normal school attendance Age 12 19 year Another disease process current demand life event might explain fatigue Another chronic disease Permanent use drug Permanently bedridden Positive pregnancy test Supine systolic blood pressure ( SBP ) &lt; 85 mm Hg Fall SPB upon stand &gt; 30 mm Hg Supine HR &lt; 50 beats/min Abnormal ECG</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>adolescent</keyword>
</DOC>